The expression of IL-17 or IL-23 was greatly enhanced in IL-1Ra KO mice, and arthritis was inhibited during IL-17 deficiency, or IL-23 blockade by anti-p19 inhibited arthritis development [32,33,34] (Table 1). Here, IL17A is linked to arthritic joint disease.